Deerfield Management Company, L.P. (Series C) Axogen, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $6.89 Million - $10.1 Million	-937,983 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $7.86 Million - $16.3 Million	937,983 New	937,983 $9.76 Million
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $20.6 Million - $34.3 Million	-1,842,330 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $11.5 Million - $19.5 Million	951,024 Added 106.7%	1,842,330 $23 Million
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $16.2 Million - $22.3 Million	-875,700 Reduced 49.56%	891,306 $17.6 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $24.3 Million - $36.8 Million	1,662,332 Added 1588.1%	1,767,006 $37.2 Million
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $1.79 Million - $4 Million	104,674 New	104,674 $2.14 Million
Q4 2017 Feb 14, 2018	SELL	$18.5 - $28.6 $6.37 Million - $9.85 Million	-344,428 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$14.65 - $19.35 $5.05 Million - $6.66 Million	344,428	344,428 $6.67 Million

Others Institutions Holding AXGN

# of Institutions

180

Shares Held

36.4M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$74.2 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$58.9 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$54.5 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$52.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$44 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account